Last reviewed · How we verify

NCT05093686: RUBIES

RUBIES in Educational Settings

Status unknown NA Last updated 8 May 2023
What this trial tests

NA trial testing RUBIES in Autism Spectrum Disorder in 240 participants. Status unknown.

Timeline
26 October 2021
Primary endpoint
30 June 2024
31 July 2024

Quick facts

Lead sponsorSeattle Children's Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment240
Start date26 October 2021
Primary completion30 June 2024
Estimated completion31 July 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Seattle Children's Hospital

Who can join

5 and older, any sex, with Autism Spectrum Disorder or Disruptive Behavior. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The proposed three-year pilot randomized trial aims to test the effectiveness of the newly-redesigned paraeducator-delivered RUBI for use in Educational Settings (RUBIES) intervention compared to usual care training in reducing disruptive behavior in 80 elementary-school children with ASD. Given the critical need to understand not just whether, but also how interventions work, this study also will examine paraeducator- and child-level mechanistic pathways of the RUBIES intervention.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Improving the Fit of Interventions for Autism in Schools: Lessons Learned Following Paraeducator Coaching on the RUBIES Program.
    Tagavi DM, Puga S, Dick C, Dahiya AV, et al · · 2025 · cited 1× · PMID 41415622 · DOI 10.1080/10474412.2025.2578840

Verify or expand the search:

Other trials of RUBIES

Trials testing the same drug.

Other recruiting trials for Autism Spectrum Disorder

Currently open trials in the same condition.

Other Seattle Children's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05093686.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing